Publications:92
Video Visit Available
Accepting New Patients
- Mount Sinai Doctors
- Treats Adults
- Video Visit Available
- Accepting New Patients
Christopher E Walsh, MD, PhD
Internal Medicine, Cancer (Oncology), Hematology-Oncology
About Me
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Education
AB, Rutgers College
PhD, Bowman Gray School of Medicine
MD, Tulane University School of Medicine
Internship, Internal Medicine
UNC Hospitals
Residency, Internal Medicine
UNC Hospitals
Residency, Internal Medicine
National Cancer Institute, NIH
Fellowship, Hematology
National Cancer Institute, NIH
Certifications
American Board of Internal Medicine
Research
Dr. Walsh directs the Hemophilia Program in the Division of Hematology and Medical Oncology at Mount Sinai School of Medicine. His research focuses on gene therapy of blood diseases. Throughout his career he has had a particular interest in Fanconi anemia and his early work in this area culminated in the first clinical trial in which retroviral vectors were used for gene therapy of patients with Fanconi anemia group C. He is also actively developing gene therapies for hemophilia A and B.
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information. Patients with Anthem Blue Cross Blue Shield (formerly known as Empire) or Molina insurance: please visit the linked pages in this message before booking to find out if out-of-network costs may apply to your next visit.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort. Jacqueline N. Poston, Cassandra Bryan, Annette von Drygalski, Kadhim Al Banaa, Jenny Y. Zhou, Aric Parnes, Evan C. Chen, Osman Khan, Patrick Ellsworth, Lorraine Cafuir, Christopher Walsh, Miguel A. Escobar, James F. Wu, Lynn M. Malec, Craig M. Kessler, Maissaa Janbain, Rebecca Kruse-Jarres. Blood advances
- Optimizing liver health before and after gene therapy for hemophilia A. Margaret V. Ragni, Henry Mead, Ype P. de Jong, Radoslaw Kaczmarek, Andrew D. Leavitt, Brian Long, Diane J. Nugent, Denise E. Sabatino, Sylvia Fong, Annette von Drygalski, Christopher E. Walsh, Bruce A. Luxon. Blood advances
- A systematic review of adeno-associated virus gene therapy clinical trials for HIV – A potential solution for patients with haemophilia and HIV?. Sarina Levy-Mendelovich, Christopher E. Walsh, Jonathan M. Schapiro, Shelly Soffer, Eyal Klang, Gili Kenet. Haemophilia
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Walsh during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Gerson Lehrman Group
- F. Hoffman-La Roche Ltd.
- Novo Nordisk
- CSL Behring
- Biomarin Pharmaceutical
- Guidepoint Global
- Pfizer Inc., U.S. Pharmaceuticals Group
- sanofi-aventis
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.